CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- Open-market buys, last 90 days
- $757,691
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$757,691. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-23 | Henry Scott Robert Director | Grant or award · Warrant to Purchase Common Stock | +5,000 | 5,000 | ||
| 2024-08-23 | Drapczuk Adam E III Chief Financial Officer | Purchase | +10,000 | $2.50 | $25K | 57,394 |
| 2024-08-23 | Drapczuk Adam E III Chief Financial Officer | Grant or award · Warrant to Purchase Common Stock | +5,000 | 5,000 | ||
| 2024-03-01 | Henry Scott Robert Director | Purchase | +23,697 | $2.11 | $50K | 135,735 |
| 2024-03-01 | Henry Scott Robert Director | Grant or award · Warrant to Purchase Common Stock | +11,848 | 11,848 | ||
| 2024-03-01 | glassman steven mark Director | Purchase | +11,848 | $2.11 | $25K | 135,025 |
| 2024-03-01 | glassman steven mark Director | Grant or award · Warrant to Purchase Common Stock | +5,924 | 5,924 | ||
| 2024-03-01 | Drapczuk Adam E III Chief Financial Officer | Purchase | +47,394 | $2.11 | $100K | 47,394 |
| 2024-03-01 | Drapczuk Adam E III Chief Financial Officer | Grant or award · Warrant to Purchase Common Stock | +23,697 | 23,697 | ||
| 2023-12-22 | glassman steven mark Director | Purchase | +3,885 | $2.20 | $9K | 123,177 |
| 2023-09-26 | Stein John Nachum Director | Purchase | +2,500 | $1.96 | $5K | 500,019 |
| 2023-09-14 | Henry Scott Robert Director | Purchase | +500 | $2.27 | $1K | 112,038 |
| 2023-09-13 | Henry Scott Robert Director | Purchase | +6,000 | $2.25 | $13K | 111,538 |
| 2023-09-12 | Henry Scott Robert Director | Purchase | +4,000 | $2.28 | $9K | 105,538 |
| 2023-08-22 | Henry Scott Robert Director | Purchase | +980 | $1.92 | $2K | 101,538 |
| 2023-08-21 | Henry Scott Robert Director | Purchase | +2,000 | $1.95 | $4K | 100,558 |
| 2023-08-17 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-08-17 | Toledano Miranda Jayne Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-08-17 | Stein John Nachum Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-08-17 | STEFANSKY DAVID Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 6 of 9 · 176 trades